VISIBLE ALPHA LAUNCHES NEW BIOPHARMA PLATFORM streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Economic uncertainty lingered as 2024 began, a year after recession predictions mercifully failed to materialize. While a hoped-for economic boom remained elusive, workers nationwide continued to grapple with inflation and
The 12 blockbuster drugs include nine medicines and vaccines with 2 billion to 5 billion euros ($2.15-$5.38 billion) in peak sales potential, and three "pipeline-in-a-product" assets with a potential of more than 5 billion euros in peak sales, Sanofi said. The France-based drugmaker said it expects its recently launched and future pharmaceutical assets to generate more than 10 billion euros ($10.76 billion) of annual sales by 2030. "We are in a privileged position today with many very promising assets in mid- and late-stage development," Sanofi's Head of Research and Development Houman Ashrafian said in a statement.